Name | Cvs Pharmacy# 00473 |
---|---|
Organization Name | Nebraska Cvs Pharmacy Llc |
Location | 1550 South St L, Lincoln, Nebraska 68502 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (402) 477-0397 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Nabi Biopharmaceuticals today announced its second quarter financial results for the three month period ended June 26, 2010. The Company reported a net loss from continuing operations of $3.4 million, or $0.08 per share, compared to a net loss of $5.8 million, or $0.11 per share, for the period ended June 27, 2009.
Patients with kidney failure who are treated with hemodialysis are at substantially increased risk of life-threatening infections.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease. A new study published in The Journal of Urology- reports that in the "PSA era," survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the disparity between African American and Caucasian men has been resolved.
Researchers from the U.S. recently reported a multimodal "SHIELD: Target, Test, and Tell" program that helped mitigate the transmission of SARS-CoV-2 at a large public university. The program also prevented community transmission and helped the continuation of in-person classes during the pandemic. This study is available on the medRxiv* preprint server.
› Verified 4 days ago
NPI Number | 1023374808 |
Organization Name | NEBRASKA CVS PHARMACY LLC |
Doing Business As | CVS PHARMACY # 00473 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 1550 South St L, Lincoln, NE 68502 |
Phone Number | 402-477-0397 |
News Archive
Nabi Biopharmaceuticals today announced its second quarter financial results for the three month period ended June 26, 2010. The Company reported a net loss from continuing operations of $3.4 million, or $0.08 per share, compared to a net loss of $5.8 million, or $0.11 per share, for the period ended June 27, 2009.
Patients with kidney failure who are treated with hemodialysis are at substantially increased risk of life-threatening infections.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease. A new study published in The Journal of Urology- reports that in the "PSA era," survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the disparity between African American and Caucasian men has been resolved.
Researchers from the U.S. recently reported a multimodal "SHIELD: Target, Test, and Tell" program that helped mitigate the transmission of SARS-CoV-2 at a large public university. The program also prevented community transmission and helped the continuation of in-person classes during the pandemic. This study is available on the medRxiv* preprint server.
› Verified 4 days ago
News Archive
Nabi Biopharmaceuticals today announced its second quarter financial results for the three month period ended June 26, 2010. The Company reported a net loss from continuing operations of $3.4 million, or $0.08 per share, compared to a net loss of $5.8 million, or $0.11 per share, for the period ended June 27, 2009.
Patients with kidney failure who are treated with hemodialysis are at substantially increased risk of life-threatening infections.
Ramucirumab (trade name: Cyramza) is a monoclonal antibody, which blocks a receptor, reducing the growth of blood vessels and so reducing blood supply to the tumours.
The routine use of prostate specific antigen (PSA) testing for screening and monitoring prostate cancer has led to early and more sensitive detection of the disease. A new study published in The Journal of Urology- reports that in the "PSA era," survival has improved for patients with newly diagnosed prostate cancer that has spread to the bones or other parts of the body and the disparity between African American and Caucasian men has been resolved.
Researchers from the U.S. recently reported a multimodal "SHIELD: Target, Test, and Tell" program that helped mitigate the transmission of SARS-CoV-2 at a large public university. The program also prevented community transmission and helped the continuation of in-person classes during the pandemic. This study is available on the medRxiv* preprint server.
› Verified 4 days ago
Able Ii Prosthetics And Orthotics Type: Medicare Supplier Location: 2222 S 16th St, Lincoln, Nebraska 68502 Phone: (402) 483-8898 | |
Acs Medical Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 233 N 48th St, Lincoln, Nebraska 68504 Phone: (402) 467-1014 | |
Ahp-mhr Homecare Llp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1801 Cushman Dr, Lincoln, Nebraska 68512 Phone: (402) 420-7744 | |
Russ's Pharmacy #1 Type: Community/Retail Pharmacy Location: 1709 Washington St, Lincoln, Nebraska 68502 Phone: (402) 474-2102 | |
Russ's Pharmacy #21 Type: Community/Retail Pharmacy Location: 1550 S Coddington Ave, Lincoln, Nebraska 68522 Phone: (402) 435-8241 |